Berbamine Hydrochloride mainly stimulates myeloid cell proliferation and promotes leukocyte proliferation. Side effects include dizziness, constipation, dry mouth and weakness. Berbamine Hydrochloride mainly has the effect of stimulating myeloid cell proliferation and differentiation to granulocytes, and also has the effects of vasodilatation, anti-myocardial hypoxia-ischemia, anti-arrhythmia, enhancement of immunity, anti-tuberculosis, and so on, which is suitable to be used for the treatment of leukopenia, as well as the prevention of leukopenia after radiotherapy and chemotherapy of cancer. Contraindications to the use of the drug include hypersensitivity to the product. Adverse reactions such as dizziness, constipation, dry mouth, weakness, paroxysmal abdominal pain, abdominal distension, etc., which can be tolerated in the process of continuing to take the drug, as well as adverse reactions such as panic and coughing, etc., may occur after the administration of the drug. Specific medication should be administered under the guidance of a specialist, and should not be used without authorization.